François Le Goff

Statistics

Publications

Citations

225

H-Index

Active since

2004

Affiliations

Idorsia (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (Switzerland)

François Le Goff is an author at Idorsia (Switzerland) specializing in drug discovery, high-throughput screening assays, and interstitial lung disease.

ORCID

Publications per year

2004–2022

Publications

Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery

Tala Shekarian, Carl Zinner, Ewelina M. Bartoszek et al. · Science Advances · 2022 · 65 citations · Full text

Medicine, Immunology, Oncology +17

SpeedScreen: The “Missing Link” between Genomics and Lead Discovery

Hartmut Zehender, François Le Goff, Natalie Lehmann et al. · SLAS DISCOVERY · 2004 · 59 citations · Full text

Pharmacy, Bioinformatics, Drug Discovery +16

NF-κB drives epithelial-mesenchymal mechanisms of lung fibrosis in a translational lung cell model

Patrick Sieber, Anny Schäfer, Raphael Lieberherr et al. · JCI Insight · 2022 · 39 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Stability of Screening Compounds in Wet DMSO

Caroline Engeloch, Ulrich Schopfer, I. Muckenschnabel et al. · SLAS DISCOVERY · 2008 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Analytical Chemistry +14

Novel high–throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors

Patrick Sieber, Anny Schäfer, Raphael Lieberherr et al. · PLoS ONE · 2018 · 31 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

1–5 of 5